Successful rituximab monotherapy for API2-MALT1 fusion positive primary mucosa-associated lymphoid tissue lymphoma of the transverse colon in a patient with liver cirrhosis
暂无分享,去创建一个
[1] K. Turetschek,et al. Activity of Rituximab plus Cyclophosphamide, Doxorubicin/Mitoxantrone, Vincristine and Prednisone in Patients with Relapsed MALT Lymphoma , 2007, Oncology.
[2] A. Iwashita,et al. Deep infiltrative low-grade MALT (mucosal-associated lymphoid tissue) colonic lymphomas that regressed as a result of antibiotic administration: endoscopic ultrasound evaluation , 2005, Journal of Gastroenterology.
[3] F. Cavalli,et al. Clinical activity of rituximab in extranodal marginal zone B-cell lymphoma of MALT type. , 2003, Blood.
[4] H. Nawata,et al. Transverse colon MALT lymphoma with nodal metastasis. , 2002, Gastrointestinal endoscopy.
[5] A. Rosenwald,et al. The t(11;18)(q21;q21) chromosome translocation is a frequent and specific aberration in low-grade but not high-grade malignant non-Hodgkin's lymphomas of the mucosa-associated lymphoid tissue (MALT-) type. , 1997, Cancer research.
[6] M. Shimizu,et al. Regression of mucosa-associated lymphoid-tissue lymphoma of rectum after eradication of Helicobacter pylori , 1997, The Lancet.
[7] P. Isaacson,et al. Malignant lymphoma of mucosa‐associated lymphoid tissue. A distinctive type of B‐cell lymphoma , 1983, Cancer.